Back to results
US 7,211,378 B2Granted
Filovirus vectors and noninfectious filovirus-based particles
AssigneeWisconsin Alumni Research Foundation
InventorsYoshihiro Kawaoka, Luke D. Jasenosky, Gabriele Neumann
Life of this patent
Estimating the term…
Abstract
Cloned filovirus genomic cDNA and methods of using the cDNA are provided. Further provided are noninfectious lipid encapsulated filovirus-based particles.
Claims14
A method to prepare lipid encapsulated replication-defective particles comprising filovirus matrix protein and a filovirus glycoprotein, comprising:
- a) providing a supernatant from a culture of eukaryotic cells contacted with a first DNA vector comprising a promoter operably linked to a DNA encoding a filovirus matrix protein or a portion thereof having residues corresponding to residues 1–226, 1–176, 50–326, or 100–326 of the Ebola virus matrix protein, which is capable of being incorporated into a particle, and a second DNA vector comprising a promoter operably linked to a DNA fragment of interest encoding a protein, wherein if the protein encoded by the DNA fragment of interest is not a glycoprotein, the culture is also contacted with a third DNA vector encoding a glycoprotein;
- and b) isolating from the supernatant replication-defective lipid encapsulated filamentous particles comprising filovirus matrix protein or the portion thereof, and the filovirus glycoprotein or the second DNA vector and the glycoprotein.
Dependencies are inferred from the claim text.